Patent Intelligence · Domain Comparison
BiotechnologyvsPharmaceuticals
Side-by-side comparison across 8 patent dimensions: portfolio size, citation quality, concentration, prosecution speed, claim breadth, expiry opportunity, and filing velocity.
Biotechnology
Patents
277
Citations
52,426
Avg citations
188.6
3yr CAGR
+12.9%
HHI
598
Expiring ≤2029
1.7%
Avg prosecution
43 mo
Avg claims
23.1
Pharmaceuticals
Patents
190
Citations
47,161
Avg citations
248.2
3yr CAGR
+19.3%
HHI
416
Expiring ≤2029
2.6%
Avg prosecution
44 mo
Avg claims
23.1
Head-to-Head Comparison
| Metric | Biotechnology | Pharmaceuticals |
|---|---|---|
| Total patents | 277▲ | 190 |
| Total citations | 52,426▲ | 47,161 |
| Avg citations/patent | 188.6 | 248.2▲ |
| 3-year CAGR | +12.9% | +19.3%▲ |
| HHI concentration | 598 | 416▲ |
| Expiring ≤2029 | 1.7% | 2.6%▲ |
| Avg prosecution (mo) | 43▲ | 44 |
| Avg claims/patent | 23.1 | 23.1 |
▲ = higher is better for that metric. HHI: lower = more competitive landscape.
Grant Trend 2015–Present
Patents granted per year by domain.
2016
2018
2020
2022
2024
2026
Domain A
Domain B
Other comparisons